Format

Send to

Choose Destination
See comment in PubMed Commons below
J Biol Inorg Chem. 2011 Jan;16(1):25-32. doi: 10.1007/s00775-010-0696-0. Epub 2010 Aug 28.

Phosphate ester cleavage promoted by a tetrameric iron(III) complex.

Author information

1
Department of Chemistry, Faculty of Science, Thaksin University, 140 Tambon Koaroobchang, Muang, Songkhla, Thailand.

Abstract

The purple acid phosphatases (PAPs) are the only binuclear metallohydrolases where the necessity for a heterovalent active site [Fe(III)-M(II) (M is Fe, Zn or Mn)] for catalysis has been established. The paradigm for the construction of PAP biomimetics, both structural and functional, is that the ligands possess characteristics which mimic those of the donor sites of the metalloenzyme and permit discrimination between trivalent and divalent metal ions. The donor atom set of the ligand 2-((2-hydroxy-5-methyl-3-((pyridin-2-ylmethylamino)methyl)benzyl)(2-hydroxybenzyl)amino)acetic acid (H(3)HPBA) mimics that of the active site of PAP although the iron(III) complex of this ligand has been characterized as the tetramer [Fe(4)(HPBA)(2)(μ-CH(3)COO)(2)(μ-O)(μ-OH)(OH(2))(2)]ClO(4)·5H(2)O. The phosphoesterase-like activity of the complex in 1:1 acetonitrile/water has now been investigated using the substrate 2,4-bis(dinitrophenyl)phosphate. The pH dependence of the catalytic rate revealed a non-symmetric bell-shaped profile, with a finite but non-zero rate at high pH. Unlike the traditional approach usually employed to analyse these bell-shaped profiles, the approach used here involved incorporating additional species which contribute to the overall activity. Employing this approach, we show that the complex has a k (cat) of 1.6 (±0.2) × 10(-3) s(-1), three kinetically relevant pK (a) values of 5.3, 6.2 and 8.4, with K (M) of 7.4 ± 0.6 mM. The kinetic parameters are similar to those reported for heterovalent PAP biomimetics. Additionally, it is observed that, unlike the enzyme, the oxidation state is not the determining factor for catalytic activity.

PMID:
20798967
DOI:
10.1007/s00775-010-0696-0
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center